Chargement de la fiche…
Chargement de la fiche…

Praticien hospitalier
Photo : PHGCOM, Public domain, Wikimedia Commons
Dans les médias
Vous êtes Dr Bruno Fautrel ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Bruno Fautrel est rhumatologue à Paris 13e (75651). Il consulte à GHU APHP SUN SITE PITIE SALPETRIERE, 47-83 — 47 Boulevard DE L HOPITAL, 75651 Paris 13e Arrondissement.
Consulter
GHU APHP SUN SITE PITIE SALPETRIERE
Dr Bruno Fautrel, c'est vous ?
Faites de cette fiche la page de votre cabinet.
47-83 — 47 Boulevard DE L HOPITAL, 75651 Paris 13e Arrondissement
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2026Annals of the rheumatic diseases73 citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
2025Annals of the rheumatic diseases11 citations
Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15
2025European journal of internal medicine10 citations
Serum interleukin-18 levels are specifically elevated in auto-inflammatory diseases involving the pyrin inflammasome: A study on 516 patients
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Bruno Fautrel consulte à GHU APHP SUN SITE PITIE SALPETRIERE, 47-83 — 47 Boulevard DE L HOPITAL, 75651 Paris 13e Arrondissement. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 01 42 16 00 00 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Paris 13e, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Innovative therapies in rheumatoid arthritis: CAR T cells and bispecific antibodies
2026EULAR rheumatology openPubMed
The EULAR points to consider regarding the development of criteria for the assessment of the disease activity in adult-onset Still's disease
2026Rheumatology (Oxford, England)PubMed
Characteristics of patients with isolated anti-Ku antibodies
2026Annals of the rheumatic diseasesPubMed
Validation of systemic Juvenile Arthritis Disease Activity Score 10 in adults with Still's disease
2026RMD openPubMed
Characteristics and outcomes of anti-Ku antibody-associated interstitial lung disease: a retrospective study of 60 patients
2026EULAR rheumatology openPubMed
Items identified by expert physicians for the development of the criteria for the assessment of disease activity for adult-onset Still's disease: results of a web-based Delphi study informing the development of the European Alliance of Associations for Rheumatology (EULAR) criteria for the assessment of disease activity in these patients
2026Nature communicationsPubMed
Adult patients with autoinflammation of unknown origin partially phenocopy the immune presentation of Still's disease
2025Annals of the rheumatic diseasesPubMed
Response to correspondence on 'Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15' by Boucly A, et al
2025Rheumatology (Oxford, England)PubMed
Exposure during pregnancy to Il-1 targeted therapies and pregnancy, foetal and neonatal outcomes: a study from the French Teratology Information Service
2025Annals of the rheumatic diseasesPubMed
Response to correspondence on: Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15
2025Annals of the rheumatic diseasesPubMed
Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15
2025RMD openPubMed
Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms
2025The Lancet. RheumatologyPubMed
The use of IL-1 and IL-6 inhibitors should be prioritised in Still's disease
2025RMD openPubMed
Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies
2025European journal of internal medicinePubMed
Serum interleukin-18 levels are specifically elevated in auto-inflammatory diseases involving the pyrin inflammasome: A study on 516 patients
2026Joint bone spinePubMed
Health care practices in symptomatic knee and hip osteoarthritis patients: The KHOALA cohort
2025Osteoarthritis and cartilage openPubMed
Association between weather features and symptoms in hand osteoarthritis: Results from the DIGICOD cohort
2025Osteoarthritis and cartilage openPubMed
Greater pain and functional impairment in chronic erosive hand osteoarthritis compared to treated rheumatoid arthritis: A comparative study
2025Arthritis & rheumatology (Hoboken, N.J.)PubMed
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
2025Frontiers in medicinePubMed
Long-term management of elderly patients with rheumatoid arthritis treated with tocilizumab: comparison of patients over and under 75 years old
2025BMJ openPubMed
Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
2026RMD openPubMed
First trimester exposure to hydroxychloroquine during pregnancy and major congenital malformations: a systematic review and meta-analysis
2026EULAR rheumatology openPubMed
Real-world epidemiology and management of patients with rheumatoid arthritis treated with methotrexate in France: a decade after methotrexate first recommendations
2025The Lancet. RheumatologyPubMed
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2026The Lancet. RheumatologyPubMed
Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study
2026Joint bone spinePubMed
Social and occupational factors are associated with musculoskeletal pain prevalence in the general population: A population-based cohort study
2025Joint bone spinePubMed
Diseases associated with anti-centromere protein F (anti-CENP-F) antibodies: Insights from a large cohort study
2026Joint bone spinePubMed
Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry
2026Rheumatology and therapyPubMed
Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
2026RMD openPubMed
Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies
2026Joint bone spinePubMed
What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?
2026European journal of nuclear medicine and molecular imagingPubMed
Diagnostic accuracy of (18)F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP)
2025Arthritis & rheumatology (Hoboken, N.J.)PubMed
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
2026Anaesthesia, critical care & pain medicinePubMed
Procedure-specific bleeding risk assessment: a multidisciplinary expert consensus companion to the 2026 periprocedural anticoagulant management guidelines
2026Joint bone spinePubMed
Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update
2026Joint bone spinePubMed
Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update. What's new?
2026RMD openPubMed
Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies
2025Advances in therapyPubMed
Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)
2025La Revue de medecine internePubMed
French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease
2025Joint bone spinePubMed
Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease and should now be designated by the same unique name, Still's disease
2026EULAR rheumatology openPubMed
Clinical, biological, and radiological changes under therapy, and criteria for clinical response and remission in adult-onset Still's disease: a systematic literature review informing the development of the European Alliance of Associations for Rheumatology (EULAR) criteria for assessing disease activity
2026Journal of Crohn's & colitisPubMed
Safety of advanced therapies during pregnancy in women with immune-mediated inflammatory diseases: a systematic review and meta-analysis
2026 · Article
What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?
2026 · Article
Procedure-specific bleeding risk assessment: a multidisciplinary expert consensus companion to the 2026 periprocedural anticoagulant management guidelines
2026 · Article
FADD Protein for the Early Diagnosis of Rheumatoid Arthritis
2026 · Article
FloREN: Decoding Immune Regulatory Networks through Interpretable Graph Transformer Patient Representations
2026 · Article
Glucocorticoid in giant cell arteritis: real-world treatment patterns over time and associated burden in a nationwide hospital-based study within the French health insurance database
2026 · Article
Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update
2026 · Article
Social and occupational factors are associated with musculoskeletal pain prevalence in the general population: a population-based cohort study
2026 · Article
Association between rheumatoid arthritis flares and joint structural changes at 24 months: using FLARE-RA questionnaire
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.